Replies to post #13520 on Anavex Life Sciences Corp (AVXL)

[TrueTrades]

Yeah, they need to put some 1s & 2s in there somewhere.

It's Full 36-day results for the 32 P2a PART A patients by end of year.

edit- This is the preliminary data we just got and weren't expecting until Sept. My speculation now is if we will get that full data in Sept-Oct???

Some patients are already enrolled and on to the 26-week P2a PART B extension study. Those first patients could be completing that part by eoy, but enrollment is, apparently, not even complete, and so the PART B could go past mid 2016. Now, they want to extend that part to 52 weeks, which would mean the patients who possibly could be done by eoy could go-on until mid 2016.

That would make the study rather..."epic".

Phase 2a Dose Finding, PK/PD and 6 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease

Nice recovery. :-D
§AVXL

[JPG77]

Okay, that makes sense. Thanks for the clarification!